Correspondence 0001493152-24-018085 from MANGOCEUTICALS, INC. (MGRX)
MANGOCEUTICALS, INC.
Date: May 7, 2024 · CIK: 0001938046 · Accession: 0001493152-24-018085
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278888
Letter
MANGOCEUTICALS, INC.
N. Dallas Parkway, Suite 600
Dallas, Texas 75248
May 7, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Attention:
Juan Grana
Re: Mangoceuticals, Inc.
Registration Statement on Form S-1
Initially filed April 23, 2024, as amended
File No. 333-278888
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mangoceuticals, Inc., hereby requests acceleration of effectiveness of the above referenced Registration Statement on Form S-1 so that it will become effective at 4:30 p.m., Eastern Daylight Time, on Thursday, May 9, 2024, or as soon thereafter as practicable.
Very
truly yours,
/s/
Jacob D. Cohen
Show Raw Text
CORRESP
1
filename1.htm
MANGOCEUTICALS,
INC.
15110
N. Dallas Parkway, Suite 600
Dallas,
Texas 75248
May
7, 2024
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Juan
Grana
Re:
Mangoceuticals,
Inc.
Registration
Statement on Form S-1
Initially
filed April 23, 2024, as amended
File
No. 333-278888
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Mangoceuticals, Inc., hereby requests acceleration of effectiveness of the
above referenced Registration Statement on Form S-1 so that it will become effective at 4:30 p.m., Eastern Daylight Time, on Thursday,
May 9, 2024, or as soon thereafter as practicable.
Very
truly yours,
/s/
Jacob D. Cohen
Jacob
D. Cohen
Chairman
and Chief Executive Officer
cc:
Lucosky
Brookman LLP